Alcon reports increase in net sales in fourth quarter, full year
Click Here to Manage Email Alerts
Alcon reported $2.1 billion in worldwide sales for the fourth quarter of 2021, according to a press release, representing an increase of 11% on a reported basis and 13% on a constant currency basis compared with the fourth quarter of 2020.
“We have secured our position as the global leader in eye care, and our 2021 performance demonstrates the resilience of our business, the strength of our innovation engine and the expertise of our commercial organization,” David J. Endicott, CEO of Alcon, said in the release.
“Our strong product flow resulted in revenue growth above-market, which drove core operating leverage and margin expansion.”
For the full year, worldwide sales totaled $8.2 billion, a 22% increase on a reported basis and a 20% increase on a constant currency basis compared with 2020.
For the fourth quarter and full year, surgical net sales totaled $1.3 billion and $4.7 billion and vision care net sales totaled $900 million and $3.5 billion, respectively, all higher compared with 2020.
“Our success is underpinned by our strategy of investing behind markets with high growth or high share opportunities,” Endicott said. “We are entering 2022 with substantial momentum, driven by innovative products that address unmet customer and patient needs. All of these factors give us confidence in our long-term strategy and in delivering shareholder value.”
Read more about
Click Here to Manage Email Alerts